Introduction

Pediatr Infect Dis J. 2019 Jun;38(6S Suppl 1):S1. doi: 10.1097/INF.0000000000002316.

Nigel Curtis^{1

2

3}, Adam Finn^{4

5

6}, Adilia Warris^{7

8}, Andrew J Pollard^{9

10}, Annemarie van Rossum¹¹, Octavio Ramilo^{12

13}

¹ From the Department of Paediatrics, The University of Melbourne.
² Infectious Diseases Unit, The Royal Children's Hospital Melbourne.
³ Infectious Diseases Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
⁴ School of Population Health Sciences and School of Cellular and Molecular Medicine, University of Bristol.
⁵ Bristol Children's Vaccine Centre.
⁶ University Hospitals Bristol NHS Foundation Trust, Bristol.
⁷ MRC Centre of Medical Mycology, Institute of Medical Sciences, University of Aberdeen.
⁸ Royal Aberdeen Children's Hospital, Aberdeen.
⁹ Department of Paediatrics, University of Oxford.
¹⁰ Children's Hospital, Oxford, United Kingdom.
¹¹ Department of Pediatrics, Division of Pediatric Infectious Diseases, Immunology and Rheumatology, Erasmus MC University Medical Center.
¹² Division of Infectious Diseases, Nationwide Children's Hospital, Columbus, Ohio.
¹³ The Ohio State University College of Medicine, Columbus, Ohio.

No abstract available

Publication types